GlaxoSmithKline PLC leaders and executives have shown their dedication by being a leading pharmaceutical company and research and development firm. GSK was named one of the 100 Best Companies for ...

This removed any intermediate doubt that weakening respiratory revenue would cause the company to drastically cut its dividend. Also, considering its 9.3 billion transaction gain, GlaxoSmithKline ...

Our data suggests that insiders own under 1% of GlaxoSmithKline plc in their own names. As it is a large company, we'd only expect insiders to own a small percentage of it. But it's worth noting ...

Incorporated in 1999, GlaxoSmithKline plc (GSK), a British company based in United Kingdom. The company was formed by a merger between Glaxo Wellcome plc and SmithKline Beecham plc. GSK is a ...

We can't gloss over the fact that GlaxoSmithKline faces challenges. Sales for the biggest revenue-generating drug in the company's lineup, Seretide/Advair, fell 16% year over year in the first ...

GlaxoSmithKline, the pharmaceutical company, said on Wednesday that it had fired Dr. Slaoui from his position as chairman of Galvani Bioelectronics. La revisión positiva probablemente asegure que ...

GlaxoSmithKline PLCGSK-0.10%decrease; red down pointing triangle on Monday said it would buy cancer-focused drug company Tesaro Inc. for about $4.16 billion, positioning the health-care giant in a ...

Glaxosmithkline Plc has filed a 13D form with the SEC disclosing ownership of 39,660,487 shares of 23andMe Holding Co. Class A (ME). This represents 13.2% of the company. 23andMe Holding Co., a ...

China has granted a green light for Glaxosmithkline plc’s human papillomavirus (HPV ... imported two-dose HPV vaccine for the age group to be approved in China, the company said. A three-dose schedule ...

News about GlaxoSmithKline PLC., including commentary and archival articles published in The New York Times.